CXCL10 and leukemia: The delivery of various transgenes that may antagonize immunoevasion mechanisms, such as the chemokine CXCL10, which activates NK cells to kill B7-H1-overexpressing dormant leukemia cells [11], could help the host in the clearance of the cancer cells.